Showing results (151-160 of 451) with videos related to

Sort By:
Pageof 46
Cancer Research|November 1, 1985
Induction of thymidine kinase activity in a spontaneously enzyme-deficient murine tumor cell line by exposure in vivo to the DNA-hypomethylating agent 5-aza-2'-deoxycytidine: implications for mechanisms of tumor progressionR G Liteplo, E Alvarez, P Frost, et al.
Kidney International|August 5, 1999
In vitro modulation of cyst formation by a novel tyrosine kinase inhibitorW E Sweeney, L Futey, P Frost, et al.
The Journal of Experimental Medicine|May 1, 1984
Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidineP Frost, R G Liteplo, T P Donaghue, et al.
The Journal of Investigative Dermatology|May 1, 1984
Morphometric studies of the hamster flank organ: an improved model to evaluate pharmacologic effects on sebaceous glandsA Weissmann, J Bowden, B Frank, et al.
Birth Defects Original Article Series|June 1, 1971
Syndrome of unilateral ectromelia, psoriasis and central nervous system anomaliesC S Shear, W L Nyhan, P Frost, et al.
Anticancer Research|September 1, 1993
p53 gene mutation spectrum in human unknown primary tumorsM Bar-Eli, J L Abbruzzese, D Lee-Jackson, et al.
Cancer Research|July 15, 1987
Rate of generation of major karyotypic abnormalities in relationship to the metastatic potential of B16 murine melanomaW S Kendal, R Y Wang, T C Hsu, et al.
Cancer Research|August 1, 1990
Synergistic cytotoxicity using 2'-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cellsP Frost, J L Abbruzzese, B Hunt, et al.
Cancer Metastasis Reviews|January 1, 1982
Tumor progression in metastasis: an experimental approach using lectin resistant tumor variantsR S Kerbel, J W Dennis, A E Largarde, et al.
Cancer Research|June 1, 1988
Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign geneE R Fearon, T Itaya, B Hunt, et al.
Pageof 46